Shivatmika,21/female, C/o unable to walk, weakness, black discoloration of fingers, slowness since 3weeks and h/o fever @1month back, management
Reading File
Finding Sources
Finding Sources
Finding Sources
Searching PubMed
post-infectious encephalitis young female weakness fever management
Finding Sources
Finding Sources
Finding Sources
Searching PubMed
autoimmune encephalitis fever weakness young adults treatment
Reading File
Finding Sources
Finding Sources
Reading File
Searching the Web
anti-NMDA receptor encephalitis young female weakness inability to walk digital ischemia blackening fingers management 2024
Now I have enough to give a comprehensive, structured answer. Let me also note from the clinical image — the patient is showing her hand over her forehead, and the dorsum of the hand/fingers shows dark hyperpigmentation/black discoloration, which in the context of this case points toward digital ischemia/gangrene — likely from a vasculitic or thromboembolic process (could be antiphospholipid syndrome, SLE with vasculitis, or septic emboli from prior infection).
Synthesizing the full clinical picture:
🧠 Clinical Analysis: Shivatmika, 21F
Key Clinical Features
| Feature | Significance |
|---|---|
| 21-year-old female | High-risk demographic for autoimmune disorders |
| Fever 1 month ago (prodrome) | Post-infectious trigger |
| Weakness + inability to walk (3 weeks) | Motor involvement — pyramidal/extrapyramidal |
| Slowness (bradyphrenia/bradykinesia) | Movement disorder component |
| Black discoloration of fingers | Digital ischemia / gangrene / vasculitis |
🔑 Most Likely Diagnosis
Anti-NMDA Receptor Encephalitis (Primary consideration)
This is the most common autoimmune encephalitis in young women (female:male = 4:1). Classic presentation:
- Fever/viral prodrome → psychiatric/neurological symptoms
- Movement disorder (dyskinesias, rigidity, slowness)
- Progressive weakness and reduced consciousness
- Young female — must rule out ovarian teratoma (present in up to 50% of affected females <45 years)
Differential Diagnoses to Exclude
| Diagnosis | Supporting Feature | Against |
|---|---|---|
| Anti-NMDAR Encephalitis | Young female, post-fever, movement disorder, weakness | Need antibody confirmation |
| ADEM (Acute Disseminated Encephalomyelitis) | Post-infectious, weakness, demyelinating | Usually more fulminant, less extrapyramidal |
| SLE with CNS vasculitis | Young female, digital ischemia, multi-system | No arthralgia/rash mentioned |
| Antiphospholipid Antibody Syndrome (APS) | Digital blackening (thrombosis), neurological | Need serology |
| Neuropsychiatric SLE | Black fingers + neuro symptoms in young female | No lupus history |
| Septic emboli (infective endocarditis) | Post-fever, digital ischemia, weakness | No cardiac symptoms mentioned |
| Scrub Typhus (tropical encephalitis) | Fever, India, multisystem | Eschar usually present |
| Dengue/Viral encephalitis | Fever prodrome | Usually more acute |
The black discoloration of fingers is the critical distinguishing clue — it points toward a vasculitic, embolic, or hypercoagulable process (APS/SLE/endocarditis) causing digital ischemia, which should run alongside the neurological workup.
🩺 Immediate Workup
Urgent Investigations
Neurological:
- MRI Brain + Spine with contrast (FLAIR, DWI, gadolinium)
- EEG (look for "extreme delta brush" pattern — specific for anti-NMDAR encephalitis)
- LP (CSF): cell count, protein, glucose, oligoclonal bands, cultures
- Serum anti-NMDAR antibodies (GluN1 subunit)
- CSF anti-NMDAR antibodies (more sensitive)
- Broader autoimmune encephalitis panel: anti-LGI1, anti-CASPR2, anti-GABA-B, anti-AMPA
Autoimmune/Vasculitis Workup (for digital ischemia):
- ANA, anti-dsDNA, anti-Smith (SLE)
- Antiphospholipid antibodies: aCL IgG/IgM, anti-β2 glycoprotein-I, Lupus anticoagulant
- Complement levels (C3, C4)
- CBC with differential (thrombocytopenia in APS/SLE)
- PT, aPTT (prolonged in lupus anticoagulant)
- Blood cultures × 3 (rule out infective endocarditis)
- Echocardiogram (TTE/TEE) — if endocarditis suspected
Tumor Surveillance:
- Pelvic USG / MRI pelvis — rule out ovarian teratoma (mandatory in young female with anti-NMDAR encephalitis)
- CT chest/abdomen/pelvis if negative
Other:
- HIV serology
- Dengue NS1/IgM, scrub typhus IgM (India — endemic)
- Vitamin B12 levels (subacute combined degeneration)
- Thyroid function + anti-TPO (Hashimoto's encephalopathy)
- Lactate, ammonia (metabolic encephalopathy)
💊 Management
Phase 1 — Acute/Emergency
- Admit to neurology ward (ICU if GCS falling, autonomic instability)
- Secure airway if consciousness decreasing
- IV access, vitals monitoring
- Antiepileptic if seizures occur (levetiracetam preferred)
Phase 2 — Immunotherapy (Anti-NMDAR / Autoimmune Encephalitis)
First-line (initiate empirically while awaiting results if clinical suspicion is high):
| Drug | Dose | Duration |
|---|---|---|
| IV Methylprednisolone | 1 g/day IV × 5 days | Then oral taper |
| IV Immunoglobulin (IVIG) | 0.4 g/kg/day × 5 days | OR |
| Plasmapheresis (PLEX) | 5–7 exchanges over 10–14 days | Alternative 1st line |
According to Bradley and Daroff's Neurology in Clinical Practice: "Acute episodes of ADEM should be treated with intravenous corticosteroids — the usual dose is 1 g/day of methylprednisolone for 5 days in adults. Refractory cases have been treated with plasmapheresis or cyclophosphamide."
Second-line (if no response in 2–4 weeks):
- Rituximab 375 mg/m² weekly × 4 doses, OR
- Cyclophosphamide IV pulses
If ovarian teratoma found:
- Urgent surgical removal (oophorectomy) — this is the definitive treatment trigger; neurological improvement often follows tumor removal
Phase 3 — Symptomatic Management
- Movement disorder / dyskinesia: Benzodiazepines (clonazepam), valproate, quetiapine
- Psychosis/agitation: Quetiapine or low-dose haloperidol (avoid high-dose antipsychotics — can worsen extrapyramidal symptoms)
- Sleep disturbance: Trazodone or clonidine
- DVT prophylaxis: LMWH (especially if APS suspected)
- Physiotherapy + Occupational therapy: Early mobilization
Phase 4 — Digital Ischemia Management
While awaiting workup:
- Keep fingers warm, avoid vasoconstrictors (nicotine, ergots)
- Aspirin + if APS confirmed → anticoagulation with warfarin/LMWH (target INR 2–3, or 3–4 if recurrent thrombosis)
- If wet gangrene / infection: IV antibiotics + urgent vascular surgery consult
- If Raynaud's/vasospasm component: nifedipine, amlodipine
- Wound care for demarcated necrotic digits
🔄 Monitoring
- Repeat MRI at 6 weeks
- Antibody titers to track treatment response
- Neuropsychological assessment for cognitive recovery
- Long-term follow-up: Risk of relapse ~20–25% in anti-NMDAR encephalitis
⚠️ Red Flags Requiring Immediate ICU Transfer
- Falling GCS / stupor / coma
- Respiratory compromise (central hypoventilation)
- Severe autonomic instability (arrhythmias, hemodynamic instability)
- Status epilepticus
- Rapidly progressive digital gangrene with systemic sepsis
Clinical Bottom Line: This 21-year-old woman with post-febrile weakness, bradykinesia, and digital blackening most likely has autoimmune/post-infectious CNS disease (anti-NMDAR encephalitis or ADEM) co-existing with or caused by a systemic process causing digital ischemia (APS, SLE vasculitis, or embolic). The workup must run in parallel — brain MRI + CSF + autoimmune antibody panel + pelvic imaging + antiphospholipid/vasculitis serology — and empiric immunotherapy should not be delayed if the clinical picture is strongly suggestive.
This is a shared conversation. Sign in to Orris to start your own chat.